This study also highlights the role of tRF-GluCTC in regulating WDR1 and its implications in HSC activation and liver fibrosis, and the molecular interactions in HSCs are expected to provide clues for subsequent target therapy. The gene discussed is WDR1; the disease is Hepatic fibrosis.